Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

Early Omicron Infection Unlikely to Protect Against Current Variants

Translator

Tempo.co

Editor

Laila Afifa

18 June 2022 12:55 WIB

TEMPO.CONew York - People infected with the earliest version of the Omicron variant of the coronavirus, first identified in South Africa in November, may be vulnerable to reinfection with later versions of Omicron even if they have been vaccinated and boosted, new findings suggest.

Vaccinated patients with Omicron BA.1 breakthrough infections developed antibodies that could neutralize that virus plus the original SARS-CoV-2 virus, but the Omicron sublineages circulating now have mutations that allow them to evade those antibodies, researchers from China reported on Friday in Nature.

Omicron BA.2.12.1, which is presently causing most infections in the United States, and Omicron BA.5 and BA.4, which now account for more than 21% of new U.S. cases, contain mutations not present in the BA.1 and BA.2 versions of Omicron.

Those newer sublineages "notably evade the neutralizing antibodies elicited by SARS-CoV-2 infection and vaccination," the researchers found in test-tube experiments.

The monoclonal antibody drugs bebtelovimab from Eli Lilly and cilgavimab, a component of AstraZeneca's Evusheld, can still effectively neutralize BA.2.12.1 and BA.4/BA.5, the experiments also showed.

But vaccine boosters based on the BA.1 virus, such as those in development by Pfizer/BioNTech and Moderna, "may not achieve broad-spectrum protection against new Omicron variants," the researchers warned.

Previous research that has not yet undergone peer review has suggested that unvaccinated people infected with Omicron are unlikely to develop immune responses that will protect them against other variants of the coronavirus.

"My personal bias is that while there may be some advantage to having an Omicron-specific vaccine, I think it will be of marginal benefit over staying current with the existing vaccines and boosters," said Dr. Onyema Ogbuagu, an infectious diseases researcher at Yale School of Medicine in New Haven, Connecticut who was not involved in the new study.

"Despite immune evasion, the expectation can be that vaccines will still protect against serious disease," Ogbuagu said. "If you're due for a booster, get a booster. What we've learned clinically is that it's most important to stay up-to-date with vaccines" to maintain high levels of COVID-19 antibodies circulating in the blood.

REUTERS

Click here to get the latest news updates from Tempo in Google News



Hajj Pilgrims Urged to Get Vaccinated First Before Departing for Pilgrimage

4 hari lalu

Hajj Pilgrims Urged to Get Vaccinated First Before Departing for Pilgrimage

A health official on Saturday, March 23, 2024, stated that Hajj pilgrims have to get vaccinated before departing for pilgrimage.


Indonesia Delivers 10mn Doses of Polio Vaccines to Afghanistan

20 hari lalu

Indonesia Delivers 10mn Doses of Polio Vaccines to Afghanistan

Afghanistan is one of the countries in the world that is categorized as a polio-endemic country.


Indonesia Mulls to Collaborate with Brazil's Fiocruz Institute in Developing Dengue Vaccine

44 hari lalu

Indonesia Mulls to Collaborate with Brazil's Fiocruz Institute in Developing Dengue Vaccine

Indonesia is exploring opportunities to collaborate with the Fiocruz Institute from Brazil to reduce dengue cases in Indonesia


Indonesia Pushes for Accelerating Procurement of Newest TB Vaccine

46 hari lalu

Indonesia Pushes for Accelerating Procurement of Newest TB Vaccine

Indonesian Health Minister Budi Gunadi Sadikin is pushing for expediting the provision of the latest Tuberculosis (TB) vaccine


Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

2 Januari 2024

Indonesia Still Provides Free COVID-19 Vaccines for 2 Vulnerable Groups

Indonesia's Health Ministry has announced that COVID-19 vaccines would remain free of charge for two vulnerable groups starting from January 1, 2024.


Indonesia Sees Rising Cases of Covid-19 Ahead of Year-end

26 Desember 2023

Indonesia Sees Rising Cases of Covid-19 Ahead of Year-end

Nearing the end of 2023, the Health Ministry recorded that the spread of Covid-19 variant JN.1 in Indonesia continues to increase, reaching 41 cases.


Indonesia's Health Ministry Reports Deaths of Two Omicron JN.1 Patients in Batam

26 Desember 2023

Indonesia's Health Ministry Reports Deaths of Two Omicron JN.1 Patients in Batam

The Indonesian Ministry of Health reports the death of two patients infected with the Omicron JN.1 and XBB.2.3.10.1 (GE.1) sub-variants of Covid-19.


Health Ministry Claims JN.1 Subvariant Under Control despite COVID-19 Case Rise

20 Desember 2023

Health Ministry Claims JN.1 Subvariant Under Control despite COVID-19 Case Rise

Health Ministry said on Tuesday that the transmission of the JN.1 subvariant of the COVID-19 virus was still under control amid rise in cases.


Health Agency: Don't Panic! COVID-19 Surge May Occur Every Six Months

14 Desember 2023

Health Agency: Don't Panic! COVID-19 Surge May Occur Every Six Months

The Jakarta Health Agency calls on the public not to panic over the recent surge in COVID-19 cases.


Jakarta Asks Pre-Elderly Residents Complete 4th Vaccine Dose Amid COVID-19 Spike

9 Desember 2023

Jakarta Asks Pre-Elderly Residents Complete 4th Vaccine Dose Amid COVID-19 Spike

Residents aged 50 and older must complete their fourth dose of COVID-19 vaccination since a spike in cases has been detected.